The Role of Clinical Pharmacist in Management of DDIs in CHF Patients

Status Recruiting

Clinical Trial Summary

Drug-drug interactions (DDIs) are common in patients with chronic heart failure (CHF) and their incidence increases with the number of drugs that the patients are prescribed for treatment of their condition. Data bases often detect DDIs that are of high clinical relevance. The investigators have performed this study in order to detect clinically significant DDIs and to diminish their occurrence by sending notification about DDIs to attending physician.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01855165
Study type	Interventional
Source	The University Clinic of Pulmonary and Allergic Diseases Golnik
Contact	Mitja Lainscak, PhD
Phone	+38642569141
Email	mitja.lainscak@guest.arnes.si
Status	Recruiting
Phase	N/A
Start date	April 2013
Completion date	December 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03597646` - The Effect of Kinesio Taping on Pulmonary Function and Functional Capacity in Patients With Chronic Heart Failure	N/A
Terminated	`NCT04065997` - Apogee International
Withdrawn	`NCT03675113` - Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure	N/A
Completed	`NCT02916160` - Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study	Phase 4
Completed	`NCT03126656` - Effects of Testosterone on Myocardial Repolarization	Phase 4
Completed	`NCT02268500` - VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)	Phase 4
Completed	`NCT02247245` - The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.	N/A
Completed	`NCT01919918` - Muscle Afferent Feedback Effects in Patients With Heart Failure	Phase 1
Terminated	`NCT01906957` - Cognition and Exercise Training	N/A
Not yet recruiting	`NCT01669395` - Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial	N/A
Completed	`NCT00984529` - Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia	N/A
Recruiting	`NCT00863421` - Sleep Disordered Breathing in Patients With Chronic Heart Failure	N/A
Completed	`NCT02840565` - Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453	Phase 1
Completed	`NCT02441218` - Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study	Phase 3
Completed	`NCT00149409` - Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure	Phase 2/Phase 3
Terminated	`NCT05532046` - A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)	Phase 1
Recruiting	`NCT04984928` - Readmission Risk of Patients With Heart Failure.
Completed	`NCT02814097` - A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction	Phase 2
Active, not recruiting	`NCT05560737` - ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
Recruiting	`NCT03286127` - Palliative Outcome Evaluation Muenster I